Four companies publicly listed on US markets during the last full week of the first quarter, raising $510 million.
Solar tech provider SolarEdge outshined its peers while mega biotech Cellectis saw speculators jump in before the IPO and then quickly jump out....read more
SolarEdge Technologies, which provides DC-optimized inverter systems for the solar industry, raised $126 million by offering 7 million shares at $18, the high end of its $16-$18 range. At $18, SolarEdge commands a fully diluted market cap of $778 million and an ...read more
In the last full week of the first quarter, the IPO market could see a billion-dollar cancer biotech and a producer of optimized solar power technology.
Three health care IPOs: a mega biotech and two small medical devices
Pre-clinical immunotherapy biotech ...read more
SolarEdge Technologies, which provides DC-optimized inverter systems for the solar industry, announced terms for its IPO on Wednesday.
The Herzilya, Israel-based company plans to raise $119 million by offering 7 million shares at a price range of $16 to $18. ...read more
US IPO Weekly Recap: SolarEdge shines while other IPOs fall flat
Four companies publicly listed on US markets during the last full week of the first quarter, raising $510 million. Solar tech provider SolarEdge outshined its peers while mega biotech Cellectis saw speculators jump in before the IPO and then quickly jump out....read more
SolarEdge Technologies prices IPO at $18, the high end of the range
SolarEdge Technologies, which provides DC-optimized inverter systems for the solar industry, raised $126 million by offering 7 million shares at $18, the high end of its $16-$18 range. At $18, SolarEdge commands a fully diluted market cap of $778 million and an ...read more
Week ahead: Up to 9 IPOs during the week of March 23 led by a billion-dollar biotech
In the last full week of the first quarter, the IPO market could see a billion-dollar cancer biotech and a producer of optimized solar power technology. Three health care IPOs: a mega biotech and two small medical devices Pre-clinical immunotherapy biotech ...read more
Souped-up solar panels: SolarEdge Technologies sets terms for $119 million IPO
SolarEdge Technologies, which provides DC-optimized inverter systems for the solar industry, announced terms for its IPO on Wednesday. The Herzilya, Israel-based company plans to raise $119 million by offering 7 million shares at a price range of $16 to $18. ...read more